No Data
No Data
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Trending Stocks Today | PainReform Surges 67.16% Post-Market
Express News | Bluebird bio Announces 1-for-20 Reverse Stock Split
Bluebird Bio Announces 1-for-20 Reverse Stock Split
FDA-Approved Sickle Cell Therapies From Bluebird Bio And Vertex Join Medicaid Innovation Program
Bluebird Bio Shares Are Trading Higher After the Company Announced It Joined the CMMI Cell and Gene Therapy Access Model and Will Offer Outcomes-based Agreements to Expand Medicaid Access to LYFGENIA Gene Therapy for Sickle Cell Disease.
Unlock the Full List